SERUM ALPHAFETOPROTEIN (AFP) IN PATIENTS WITH GERM-CELL TUMORS OF THE GONADS AND EXTRAGONADAL SITES - CORRELATION BETWEEN ENDODERMAL SINUS (YOLK-SAC) TUMOR AND RAISED SERUM AFP

被引:0
|
作者
TALERMAN, A
HAIJE, WG
BAGGERMAN, L
机构
[1] INST RADIOTHERAPY,DEPT PATHOL,ROTTERDAM,NETHERLANDS
[2] INST RADIOTHERAPY,DEPT CHEM PATHOL,ROTTERDAM,NETHERLANDS
关键词
D O I
10.1002/1097-0142(19800715)46:2<380::AID-CNCR2820460228>3.0.CO;2-U
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:380 / 385
页数:6
相关论文
共 33 条
  • [21] FREQUENCY OF SERUM TUMOR-MARKER MONITORING IN PATIENTS WITH NONSEMINOTAMOUS GERM-CELL TUMORS
    SECKL, MJ
    RUSTIN, GJS
    BAGSHAWE, KD
    BRITISH JOURNAL OF CANCER, 1990, 61 (06) : 916 - 918
  • [22] FREQUENCY OF SERUM TUMOR-MARKER MONITORING IN PATIENTS WITH NON-SEMINOMATOUS GERM-CELL TUMORS
    SECKL, MJ
    RUSTIN, GJS
    BAGSHAWE, KD
    BRITISH JOURNAL OF CANCER, 1989, 59 (05) : 822 - 823
  • [23] THE PROGNOSTIC-SIGNIFICANCE OF ENDODERMAL SINUS TUMOR HISTOLOGY AMONG PATIENTS TREATED FOR STAGE-III NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTES
    LOGOTHETIS, CJ
    SAMUELS, ML
    TRINDADE, A
    GRANT, C
    GOMEZ, L
    AYALA, A
    CANCER, 1984, 53 (01) : 122 - 128
  • [24] SERUM TUMOR-MARKERS IN PATIENTS WITH METASTATIC GERM-CELL TUMORS OF THE TESTIS - A 10-YEAR EXPERIENCE
    BOSL, GJ
    GELLER, NL
    CIRRINCIONE, C
    NISSELBAUM, J
    VUGRIN, D
    WHITMORE, WF
    GOLBEY, RB
    AMERICAN JOURNAL OF MEDICINE, 1983, 75 (01): : 29 - 35
  • [25] SERUM HORMONE LEVELS IN PATIENTS WITH MALIGNANT TESTICULAR GERM-CELL TUMORS WITHOUT CLINICAL AND-OR RADIOLOGICAL SIGNS OF TUMOR
    FOSSA, SD
    KLEPP, O
    AAKVAAG, A
    BRITISH JOURNAL OF UROLOGY, 1980, 52 (02): : 151 - 157
  • [26] SURGICAL RESECTION OF SOLITARY METASTASES AFTER CHEMOTHERAPY IN PATIENTS WITH NONSEMINOMATOUS GERM-CELL TUMORS AND ELEVATED SERUM TUMOR-MARKERS
    WOOD, DP
    HERR, HW
    MOTZER, RJ
    REUTER, V
    SOGANI, PC
    MORSE, MJ
    BOSL, GJ
    CANCER, 1992, 70 (09) : 2354 - 2357
  • [27] Correlation between serum cytokine/angiogenic factors (CAFS) and tumor markers in testicular germ cell tumor patients.
    Svetiovska, Daniela
    Mego, Michal
    Cholujova, Dana
    Gronesova, Paulina
    Palacka, Patrik
    Vanda, Usakova
    Miskovska, Vera
    Vetrakova-Krakovska, Bibiana
    Luha, Jan
    Mardiak, Jozef
    CANCER RESEARCH, 2013, 73 (08)
  • [28] EVALUATION OF 5 TUMOR-MARKERS (AFP, CEA, HCG, HPL AND SP1) IN MONITORING THERAPY AND FOLLOW-UP OF PATIENTS WITH TESTICULAR GERM-CELL TUMORS
    SZYMENDERA, JJ
    ZBORZIL, J
    SIKOROWA, L
    LENKO, J
    KAMINSKA, JA
    GADEK, A
    ONCOLOGY, 1983, 40 (01) : 1 - 10
  • [29] Outcome following resection for patients with primary mediastinal nonseminomatous germ-cell tumors and rising serum tumor markers post-chemotherapy
    Radaideh, S. M.
    Cook, V. C.
    Kesler, K. A.
    Einhorn, L. H.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 804 - 807
  • [30] PROGNOSTIC-SIGNIFICANCE OF SERUM TUMOR BIOMARKERS (TM), ALPHA-FETOPROTEIN (AFP), BETA-SUBUNIT OF HUMAN CHORIONIC-GONADOTROPIN (BHCG), AND LACTATE-DEHYDROGENASE (LDH) IN NONSEMINOMATOUS GERM-CELL TUMORS (NSGCT)
    FRIEDMAN, A
    VUGRIN, D
    GOLBEY, RB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 323 - 323